Allergy Therapeutics plc (LON:AGY), the fully integrated speciality pharmaceutical group specialising in allergy vaccines, today provided a trading update for the year ended 30 June 2017 ahead of its Preliminary Results
A Flexicon FMB210L fully automatic vial filling and screw capping machine from Watson-Marlow Fluid Technology Group (WMFTG) has boosted output by 300% at a major pharmaceutical company, dedicated to reducing the impact
Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, today announces that two preclinical studies carried out through its Bencard Adjuvant Systems division have been published in
Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, is hosting a site visit at its corporate headquarters for sell-side analysts today and institutional investors
Allergy Therapeutics (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, said today that a satellite symposium entitled: “The Best Therapies by Design” was held at the 36(th)
Allergy Therapeutics plc (LON:AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, announced tody the appointment of Dr Tunde Otulana to its Board of Directors as a Non-Executive
The sneezing, watery eyes and runny noses from seasonal allergies are poised to land more people in the emergency room as temperatures rise, researchers have found. In a study published
Allergy Therapeutics Plc (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. Pollinex Quattro continues to gain market share despite being available in EU only on
Allergy Therapeutics Plc (LON:AGY) the UK-based, specialty pharmaceutical company focused on the development, manufacture and sale of vaccines and other products for the treatment and prevention of allergies, today reported
Commenting on the interim results, Allergy Therapeutics plc LON:AGY Manuel Llobet, Chief Executive Officer, said: “In the first half of this year, we delivered an increase of 18% in revenue
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
